Browsing by Author "Dinc A."

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
    (2010) Avouac J.; Walker U.; Tyndall A.; Kahan A.; Matucci-Cerinic M.; Allanore Y.; Miniati I.; Müller A.; Iannone F.; Giacomelli R.; Distler O.; Becvar R.; Sierakowsky S.; Kowal-Bielecka O.; Coelho P.; Cabane J.; Cutolo M.; Shoenfeld Y.; Valentini G.; Rovensky J.; Riemekasten G.; Nicoara I.; Vlachoyiannopoulos P.; Caporali R.; Jiri S.; Inanc M.; Gorska I.Z.; Carreira P.; Novak S.; Czirjak L.; Ramos F.O.; Jendro M.; Chizzolini C.; Kucharz E.J.; Richter J.; Cozzi F.; Rozman B.; Mallia C.M.; Gabrielli A.; Farge D.; Kiener H.P.; Schöffel D.; Sticherling M.; Airo P.; Wollheim F.; Martinovic D.; Trotta F.; Hunzelmann N.; Jablonska S.; Reich K.; Bombardieri S.; Siakka P.; Pellerito R.; Bambara L.M.; Morovic-Vergles J.; Denton C.; Hinrichs R.; Van Den Hoogen F.; Damjanov N.; Kötter I.; Ortiz V.; Heitmann S.; Krasowska D.; Seidel M.; Hasler P.; Van Laar J.M.; Kaltwasser J.P.; Foeldvari I.; Juan Mas A.; Bajocchi G.; Wislowska M.; Pereira Da Silva J.A.; Jacobsen S.; Worm M.; Graniger W.; Kuhn A.; Stankovic A.; Cossutta R.; Majdan M.; Rajcevska L.D.; Tikly M.; Nasonov E.L.; Steinbrink K.; Herrick A.; Müller-Ladner U.; Dinc A.; Scorza R.; Sondergaard K.; Indiveri F.; Nielsen H.; Szekanecz Z.; Silver R.M.; Antivalle M.; Espinosa I.B.; García De La Pena Lefebvre P.; Midtvedt O.; Launay D.; Valesini F.; Tuvik P.; Ionescu R.M.; Del Papa N.; Pinto S.; Wigley F.; Mihai C.; Capranu M.S.; Sunderkötter C.; Jun J.B.; Derk C.; Alhasani S.; Distler J.H.; Ton E.; Soukup T.; Seibold J.; Zeni S.; Nash P.; Mouthon L.; De Keyser F.; Duruöz M.T.; Cantatore F.P.; Strauss G.; Von Mülhen C.A.; Pozzi M.R.; Eyerich K.; Szechinski J.; Keiserman M.; Houssiau F.A.; Rom-Ivorra J.A.; Krummel-Lorenz B.; Aringer M.; Westhovens R.; Bellisai F.; Mayer M.; Stoeckl F.; Üprus M.; Volpe A.; Buslau M.; Yavuz S.; Granel B.; Feijó A.V.; Del Galdo F.; Popa S.; Zenone T.; Machado X.R.; Pileckyte M.; Stebbings S.; Mathieu A.; Tulli A.; Tourinho T.; Souza R.; Acayaba De Toledo R.; Stamp L.; Solanki K.; Veale D.; Neto J.F.M.; Bagnato G.F.; Loyo E.; Toloza S.; Li M.; Mohamed W.A.A.A.; Cobankara V.; Olas J.; Salsano F.; Oksel F.; Tanaseanu C.M.; Foti R.; Ancuta C.; Vonk M.; Caramashi P.; Beretta L.; Balbir A.; Shine B.; Chiàla A.; Simic K.P.; Ghio M.; Stamenkovic B.; Rednic S.; Host N.; Hachulla E.; Furst D.E.
    Objective. To determine the prevalence of and independent factors associated with joint involvement in a large population of patients with systemic sclerosis (SSc). Methods. This study was cross-sectional, based on data collected on patients included in the European League Against Rheumatism (EULAR) Scleroderma Trials and Research (EUSTAR) registry. We queried this database to extract data regarding global evaluation of patients with SSc and the presence of any clinical articular involvement: synovitis (tender and swollen joints), tendon friction rubs (rubbing sensation detected as the tendon was moved), and joint contracture (stiffness of the joints that decreased their range of motion). Overall joint involvement was defined by the occurrence of synovitis and/or joint contracture and/or tendon friction rubs. Results. We recruited 7286 patients with SSc; their mean age was 56 ± 14 years, disease duration 10 ± 9 years, and 4210 (58%) had a limited cutaneous disease subset. Frequencies of synovitis, tendon friction rubs, and joint contractures were 16%, 11%, and 31%, respectively. Synovitis, tendon friction rubs, and joint contracture were more prevalent in patients with the diffuse cutaneous subset and were associated together and with severe vascular, muscular, renal, and interstitial lung involvement. Moreover, synovitis had the highest strength of association with elevated acute-phase reactants taken as the dependent variable. Conclusion. Our results highlight the striking level of articular involvement in SSc, as evaluated by systematic examination in a large cohort of patients with SSc. Our data also show that synovitis, joint contracture, and tendon friction rubs are associated with amore severe disease and with systemic inflammation. The Journal of Rheumatology Copyright © 2010. All rights reserved.
  • No Thumbnail Available
    Item
    The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey
    (2012) Malhan S.; Pay S.; Ataman S.; Dalkilic E.; Dinc A.; Erken E.; Ertenli I.; Ertugrul E.; Gogus F.; Hamuryudan V.; Inanc M.; Karaaslan Y.; Karadag O.; Karakoc Y.; Keskin G.; Kisacik B.; Kiraz S.; Oksel F.; Oksuz E.; Pirildar T.; Sari I.; Soy M.; Senturk T.; Taylan A.
    Objectives: To determine the direct and indirect costs due to rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients in Turkey. Methods: An expert panel was convened to estimate the direct and indirect costs of care of patients with RA and AS in Turkey. The panel was composed of 22 experts chosen from all national tertiary care rheumatology units (n=53). To calculate direct costs, the medical management of RA and AS patients was estimated using "cost-of-illness" methodology. To measure indirect costs, the number of days of sick leave, the extent of disability, and the levels of early retirement and early death were also evaluated. Lost productivity costs were calculated using the "human capital approach", based on the minimum wage. Results: The total annual direct costs were 2,917.03 Euros per RA patient and 3,565.9 Euros for each AS patient. The direct costs were thus substantial, but the indirect costs were much higher because of extensive morbidity and mortality rates. The total annual indirect costs were 7,058.99 Euros per RA patient and 6,989.81 for each AS patient. Thus, the total cost for each RA patient was 9,976.01 Euros and that for an AS patient 10,555.72 Euros, in Turkey. Conclusion: From the societal perspective, both RA and AS have become burden in Turkey. The cost of lost productivity is higher than the medical cost. Another important conclusion is that indirect costs constitute 70% and 66% of total costs in patients with RA and AS, respectively. © Clinical and Experimental Rheumatology 2012.